Efficacy and Safety of Adjunctive Cannabidiol in Patients with Lennox–Gastaut Syndrome: A Systematic Review and Meta-Analysis

Overview of attention for article published in CNS Drugs, August 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (73rd percentile)
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

policy: 1 policy source

twitter: 7 X users

Citations

dimensions_citation: 52 Dimensions

Readers on

mendeley: 110 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 33,206 followers.

Lennox–Gastaut syndrome (LGS) is a severe developmental epileptic encephalopathy. Adjunctive cannabidiol resulted in a greater reduction in seizure frequency and a higher rate of AEs than placebo in 2 RCTs https://t.co/gILMWU3SQq

20 Oct 2018

Reply Repost Favourite

#lennoxgastaut #cbd #clinicalresearch https://t.co/x55hTU3fSh

23 Aug 2018

Reply Repost Favourite

RT @drpaolandmd: In this systematic review adjunctive #CBD resulted in a greater reduction in #seizures frequency and a higher rate of adve…

23 Aug 2018

Reply Repost Favourite

RT @drpaolandmd: In this systematic review adjunctive #CBD resulted in a greater reduction in #seizures frequency and a higher rate of adve…

23 Aug 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.